Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nemaura Medical Inc. - Common Stock (NQ:NMRD)

0.1053 UNCHANGED
Last Price Updated: 4:00 PM EST, Jan 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Nemaura Medical Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Releases Status Update Regarding Listing, Strategic Direction
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces Positive Nasdaq Listing Decision
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Secures $10M Credit Facility to Drive Growth
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Releases Q3 2023 Report, Unveils New Direct-to-Consumer Metabolic Health Program Offering
Via Investor Brand Network
Sidoti Events, LLC’s Virtual November Micro-Cap Conference
Via ACCESSWIRE
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces Appointment of Strategic AI Advisor
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) to Present at Emerging Growth in A.I. Conference
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
BioMedNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Issues Update on Nasdaq Compliance Status
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Issues Update on Nasdaq Compliance Status
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces Interim Results from Its Miboko Program
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) to Participate at HLTH 2023
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Reports Interim Results for 100-Patient Study for sugarBEAT(R)
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Secures SFDA Approval for sugarBEAT(R)
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Releases Q1 2023 Financial, Business Report
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Reports on $6.5M Non-Dilutive Funding
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Releases Fiscal Year Financial Report, Corporate Update
Via Investor Brand Network
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Supply Chain
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Takes Another Step in Commercialization of proBEAT(TM) Platform
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) to Participate at Upcoming Collision Conference
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) to Showcase Technology at World’s Premier Diabetes Education Event
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces Participating in EF Hutton Fireside Chat
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Expands EU DuoPack Agreement by Including Insulin as Eligible Drug
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces Q3 2023 Results, Provides Business Update
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces Participation at MicroCap Rodeo Winter Wonderland Best Ideas 2023 Conference
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Nemaura Medical, Inc. (NASDAQ: NMRD) Featured in Coverage of The MicroCap Rodeo’s 3rd Annual Winter Wonderful and Best Ideas Investor Conference
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Secures ~$8.4M in Registered Direct Offering and Concurrent Private Placement
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces Pricing of ~$8.4M Registered Direct Offering and Concurrent Private Placement
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces $500K PO from U.S. Health Provider HealthFleet
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Nemaura Medical Receives First Purchase Order from U.S. Health Provider HealthFleet
From Nemaura Medical, Inc.
Via Business Wire
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Reports Promising Initial Results from UK NHS Miboko Study
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Nemaura Medical Reports Initial Patient Data from UK NHS Miboko Study that Demonstrates Weight Loss in 100% of Participants
From Nemaura Medical, Inc.
Via Business Wire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.